✦ LIBER ✦

Endpoints in Clinical Trials for Hepatocellular Carcinoma

Book ID: 117374258
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 900 KB
Volume: 45
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)00471-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical research in hepatocellular carc

Clinical research in hepatocellular carcinoma: Study design and endpoints

✍ Alejandro Forner; Sasan Roayaie 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Surrogate endpoints in clinical trials

✍ Lawrence Friedman; Salim Yusuf 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Compound endpoints in clinical trials

✍ Michael Terrin; Sandra Forman 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Surrogates for Fracture Endpoints in Cli

Surrogates for Fracture Endpoints in Clinical Trials

✍ Sundeep Khosla 📂 Article 📅 2003 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 87 KB

41IN ENDPOINTS IN CLINICAL TRIALS

✍ Pirker, R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 85 KB

A rationale for expanding the endpoints

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma

✍ Mace L. Rothenberg; James L. Abbruzzese; Malcolm Moore; Russell K. Portenoy; Joh 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 689 KB

## BACKGROUND. Using classical endpoints, such as response rate and survival, as the sole measures of benefit, little progress has been made in the treatment of advanced pancreatic carcinoma in the past 30 years. We challenge the assumption that response rate and survival are the only appropriate